Dorsata, a NYC-based provider of a platform for the creation, distribution and implementation of clinical carepaths, raised $1.1m in seed funding.
The round was led by QED Investors with participation from 5 Cap Ventures, 1776, the Partnership Fund for NYC, and the co-founders of Sheridan Healthcare, a $2.5bn physician services company. In conjunction with the funding, Peter Hotz of 5 Cap Ventures, joined Dorsata’s board.
The company will use the funds to hire full-stack software engineers and business development professionals and grow the community of clinicians that use the platform.
Led by CEO David Fairbrothers, Dorsata provides a software platform that allows clinicians to improve collaboration and review clinical care pathways. Over 1500 clinicians already use the software every day to reduce the amount of time spent doing tasks like documentation and data entry – thereby freeing them up to focus on patients.
The company is currently involved in the rollout of the platform at Barnes-Jewish in St. Louis and Penn Medicine in Philadelphia.